Comparing Medium-Term Clinical Outcomes following XEN® 45 and XEN® 63 Device Implantation

PURPOSE: To evaluate medium-term clinical outcomes with XEN® 45 or XEN® 63 Gel Stent (Allergan, Dublin, Ireland) for treatment of primary open angle glaucoma (POAG). Materials and Methods. Retrospective, descriptive, and observational study involving 40 patients implanted with a XEN® 45 Gel Stent an...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Ophthalmol
Asıl Yazarlar: Fernández-García, Aitor, Zhou, Ying, García-Alonso, Mercedes, Andrango, Henry D., Poyales, Francisco, Garzón, Nuria
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi 2020
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7125472/
https://ncbi.nlm.nih.gov/pubmed/32280523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/4796548
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller